Exelon Corp's (NYSE:EXC) short interest as a percent of float has risen 10.43% since its last report. According to exchange reported data, there are now 32.41 million shares sold short, which is 4.13% of all regular shares that are available for trading. Based on its trading volume, it would take... Read more
Benzinga - Nov 27
FGFTRebDREXELMinM-AM-AO-TAPFPTSPanov262-70-31-2045Turner163-70-04-7146Blakeney353-183-31-72310Garcia Adsten305-61-24-111212Vanderhorst284-70-01-41210Reed263-115-62-41112Beard183-80-00-1117de LaPorterie151-30-02-4133Akuta40-20-00-0100Tingler30-00-00-0010Totals20024-699-1415-4092165 Read more
Bluefield Daily Telegraph - Nov 08
Exelixis Inc. (NASDAQ:EXEL) stock is trading lower on Monday after the company shared detailed results from the STELLAR-303 Phase 3 trial.The trial evaluated zanzalintinib plus Roche Holdings AG’s (OTC:RHHBY) Tecentriq (atezolizumab) versus Bayer AG’s (OTC:BAYRY) Stivarga (regorafenib) for previo... Read more
Benzinga - Oct 20
19 analysts have shared their evaluations of Exelixis (NASDAQ:EXEL) during the recent three months, expressing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to... Read more
Benzinga - Aug 12
